Company profile: Basepaws
1.1 - Company Overview
Company description
- Provider of at-home genetic testing for cats and dogs, including cat and dog DNA tests for breed analysis, trait information, and health risk markers; cat oral microbiome tests to screen for dental diseases; and whole genome sequencing for cats providing extensive genome data on health, traits, and breed.
Products and services
- Whole Genome Sequencing for Cats: Comprehensive genetic analysis offering extensive data across a cat’s genome, delivering insights into health, traits, and breed information
- Basepaws Cat DNA Test: Direct-to-consumer genetic test revealing breed composition, health risks, and physical traits, translating results into actionable insights to help owners make informed, proactive health decisions
- Basepaws Dog DNA Test: At-home DNA test offering detailed breed analysis, health risk markers, and trait information to assist in personalized care planning
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Basepaws
Scipher Medicine
HQ: United States
Website
- Description: Provider of a healthcare platform to determine which drug will work best for each patient, offering PrismRA, a blood test that predicts non-response to TNF inhibitors in rheumatoid arthritis; Spectra, a platform that discovers novel drug targets by analyzing patient molecular data and the human interactome; and PrismUC, a diagnostic test for ulcerative colitis utilizing molecular data to guide treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scipher Medicine company profile →
Correlagen
HQ: United States
Website
- Description: Provider of genetic testing that helps physicians diagnose diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Correlagen company profile →
MaaT Pharma
HQ: France
Website
- Description: Provider of microbiome ecosystem therapies to restore patient–microbiome symbiosis and improve outcomes in cancers and GvHD. Offers MET-N and MET-C candidates, MaaT013 for acute GvHD, MaaT033 to improve survival post allo-HSCT, and MaaT03X to enhance response to immune checkpoint inhibitors in solid tumors, plus gutPrint, an AI platform for MET design, and cGMP manufacturing for standardized microbiome-based drug candidates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MaaT Pharma company profile →
Decipher Bio
HQ: United States
Website
- Description: Provider of genomic tests for urological cancers, including Decipher Prostate for risk scores to guide treatment decisions and Decipher Bladder for molecular subtyping to aid planning, and the Decipher GRID research platform of whole-transcriptome profiles. Continues to build its GRID database and partners with pharmaceutical companies to identify biomarkers of response to novel therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decipher Bio company profile →
Crescendo Bioscience
HQ: United States
Website
- Description: Provider of quantitative, objective diagnostic tools for rheumatologists, delivering clinical insights to manage patients with autoimmune and inflammatory diseases. Provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crescendo Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Basepaws
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Basepaws
2.2 - Growth funds investing in similar companies to Basepaws
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Basepaws
4.2 - Public trading comparable groups for Basepaws
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →